Results 111 to 120 of about 941,634 (294)

Liver Injury with Features Mimicking Autoimmune Hepatitis following the Use of Black Cohosh

Case Reports in Medicine, 2009
There are a growing number of cases detailing acute hepatic necrosis in patients taking black cohosh (Cimicifuga racemosa), an over-the-counter herbal supplement for management of menopausal symptoms.
Grace Guzman, Eric R. Kallwitz, Christina Wojewoda, Rohini Chennuri, Jamie Berkes, Thomas J. Layden, Scott J. Cotler   +6 more
doaj   +1 more source

Acute Hepatitis E Mimicking a Flare of Disease in a Patient with Chronic Autoimmune Hepatitis

Annals of Hepatology, 2017
Acute hepatitis E is becoming increasingly recognised in Europe with up to 40% of the population in Southern France being exposed to the virus, which is harboured in pigs. Patients with known liver disease may present with acute hepatitis E and present a
Giorgio Calisti, Dianne N Irish, Samreen Ijaz, Richard S Tedder, Kevin Moore   +4 more
doaj   +1 more source

Clinical observations of giant cell hepatitis in children

Журнал инфектологии, 2019
Giant cell hepatitis is characterized, by inflammation and large multinucleated. hepatocytes in hepatic parenchyma It is an unusual hepatocytes response to various noxious stimuli, characterized, by presence of multinucleated cells in liver with ...
E. N. Sergienkci, O. N. Romanova, A. A. Klyuchareva, N. V. Klimovich, S. K. Kletskiy, I. V. Sakharov, T. I. Lisitskaya, A. M. Kashkan, M. D. Ocheretny, E. A. Buldyk, V. P. Grinchak, Yu. V. Strizhak   +11 more
doaj   +1 more source

Etiopathogenesis of autoimmune hepatitis.

Journal of Autoimmunity, 2018
Autoimmune hepatitis is a chronic inflammatory liver disease characterized by hypergammaglobulinemia, the presence of autoantibodies, and inflammation within the liver, including lymphocytic infiltrates and interface hepatitis. Autoimmune hepatitis shows
A. Floreani, Paula Restrepo-Jiménez, M. Secchi, Sara De Martin, P. Leung, E. Krawitt, C. Bowlus, M. Gershwin, J. Anaya   +8 more
semanticscholar   +1 more source

Tolerability of Adjuvant Nivolumab in Esophageal or Gastroesophageal Junction Cancer: A Real‐World Study

International Journal of Cancer, EarlyView.
ABSTRACT Adjuvant nivolumab is approved for esophageal or gastroesophageal junction cancer after neoadjuvant chemoradiotherapy and resection. In the CheckMate‐577 trial, Grade 3–5 nivolumab‐related adverse events (AEs) occurred in 5% of patients, with early discontinuation due to toxicity in 9%. However, real‐world data on immunotherapy‐related adverse
Michelle Koops van ’t Jagt, Anniek Strijdhorst, Tamara Jessica Huizer, Esther Albertien Kleibeuker, Sarah Derks, Bianca Mostert, Hanneke van Laarhoven, Jacco Juri de Haan   +7 more
wiley   +1 more source

Autoimmune Hepatitis.

Internal Medicine, 1993
TODA, Gotaro, ZENIYA, Mikio
openaire   +6 more sources

Hepatitis as the presenting symptom of childhood systemic lupus erythematosus

The Turkish Journal of Pediatrics, 1999
We report in this article a girl with an initial diagnosis of autoimmune hepatitis who developed full-blown systemic lupus erythematosus (SLE) at her two-years follow-up.
R A Apak, N Beşbaş, S Ozdemir, H Ozen, A Bakkaloğlu, U Saatçi   +5 more
doaj  

Overlap of Wilson’s disease and autoimmune hepatitis: a case report

Zdorovʹe Rebenka, 2019
The article presents review of literature and observation of the clinical case of Wilson’s disease combined with autoimmune hepatitis in an adolescent. The questions of the diagnosis of autoimmune hepatitis and Wilson’s disease in children are considered
N.Yu. Zavhorodnia, O.Yu. Lukianenko, N.O. Zhigir   +2 more
doaj   +1 more source

Grand round: Autoimmune hepatitis.

Journal of Hepatology, 2019
Autoimmune hepatitis is a corticosteroid-responsive liver disease arising consequent to immunogenetic and environmental risk factors. The clinical course reflects relapsing and remitting, hepatocyte targeted immunologic damage, which is countered by ...
P. Trivedi, Stefan G. Hubscher, M. Heneghan, Dermot Gleeson, G. Hirschfield   +4 more
semanticscholar   +1 more source

Diabetes Increases Immunotherapy‐Related Toxicity but Not Efficacy in Metastatic Non‐Small Cell Lung Cancer: A Multicenter Retrospective Study

International Journal of Cancer, EarlyView.
ABSTRACT This multicenter retrospective study evaluated the impact of type 2 diabetes mellitus (DM) on clinical outcomes and immune‐related adverse events (irAEs) in 450 patients with metastatic non‐small cell lung cancer (NSCLC) treated with second‐line nivolumab at 17 centers between 2016 and 2024. Among these patients, 118 (26.2%) had DM.
Emre Çakır, Didem Divriklioğlu, Deniz Can Güven, Gamze Serin Özel, Oğuzhan Yıldız, Gamze Emin, Merve Keskinkılıç, Yeşim Ağyol, Onur Yazdan Balçık, Nagihan Kolkıran, Hale Gülçin Yıldırım Doğan, Pervin Can Şancı, Özge Yalıcı, Teoman Şakalar, Yurdagül Danacı, Yakup Düzköprü, Canan Yıldız, Mesut Yılmaz, İlhan Hacıbekiroğlu, Bülent Erdoğan, Saadettin Kılıçkap, Gamze Gököz Doğu, Melek Karakurt Eryılmaz, Atila Yıldırım, İlhan Öztop, İbrahim Vedat Bayoğlu, Şahnura Uzuntaş, Atike Pınar Erdoğan, Emir Çelik, Devrim Çabuk, Erdoğan Selçuk Şeber, Zehra Sadak Öcal, Hacer Demir   +32 more
wiley   +1 more source